Rise Above Covid

What is the ACTIV‑2 Study?

spreading coronavirus through coughing

The ACTIV-2 Study is testing different medicines to see if they are safe and can help adults with COVID-19. Finding treatments for COVID-19 is important because the virus is spreading quickly all over the world and can cause serious sickness and even death.

Researchers want to see if the medicines are:

photo

Safe

photo

Can help people get better faster

photo

Can get rid of the virus

photo

Can keep people from getting sicker

photo

Can prevent people from having to go to the hospital

Who can be in the ACTIV-2 Study?

The ACTIV-2 Study is for adults 18 years and older who:

photo

Tested positive for COVID-19 (not more than 7 days ago)

photo

Are at home (not in the hospital)

photo

Have COVID-19 symptoms

You must have had at least one of the symptoms below within the last 10 days. In addition, you must have at least 1 of the symptoms shown below in blue within the last 2 days.

illustration of COVID 19 symptoms

What happens during the study?

The study lasts about 6 months. You will have in person visits to check on the status of your health. Most of these visits will happen during the first month of the study. You will also have phone calls or video chats from your home with a researcher.

v

1. Permission

If you agree to be in the study, you will give your permission by signing an informed consent form.

The informed consent contains all of the important information about the study. Ask questions and make sure you understand the study before signing the form.

v

2. Screening

You will answer some questions to make sure the study is right for you.

The screening may take place during a visit with a researcher, over the phone, or by video chat. If you meet with the researcher, you may also have a checkup.

v

3. Entry visit

You will meet with a researcher for tests and to be placed in a treatment group.

You will have some tests to check your heart, lungs, and general health, as well as a blood test and a nose swab. You will be placed in a treatment group by chance, like flipping a coin.

v
6 months (24 weeks)

4. Treatment and clinic visits

Take the medicine exactly as the researcher explains to you. You will also have up to 7 visits with a researcher for tests and up to 5 phone calls from home with the researcher or nurse.

6 months (24 weeks)

Most of the visits happen during the first 28 days of the study. You may have some of the following tests/health checks:

tests you will take during the study

How do I enroll in the study?

Have you tested positive for COVID-19 in the past 6 days? If so, you may be a good fit to join the ACTIV-2 Study and help us find a treatment for
COVID-19! Call to learn more.

(877) 345-8813

Being in the study is completely voluntary. You can leave the study at any time.

Treatment vs Vaccine Study

Treatment Information

You have probably heard about vaccine studies. But, what are treatment studies, and how do they differ?

Learn about different types of medicines that are being studied in the ACTIV-2 Study.

WE CAN RISE ABOVE COVID,
BUT WE CAN’T DO IT
WITHOUT YOU.

© 2020 JUMO HEALTH, INC. ALL RIGHTS RESERVED.

PRIVACY POLICYTERMS OF USESITEMAP

This site is intended for United States residents only. ACTIV-2 Study - Website - 21-Sep-2020 - V2.1